
ICON Public Limited Company ICLR
$ 177.7
-2.69%
Annual report 2024
added 01-10-2026
Country |
|
IPO year |
1998 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
82.5 M |
Market Cap[1] |
$ 14.7 B |
EBITDA (LTM) |
$ 723 M |
P/E (LTM) |
53.08 |
P/S (LTM) |
2.74 |
EPS (LTM) |
3.44 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.1 | -2.82 % | $ 101 K | Nasdaq Capital Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
BioNano Genomics
BNGO
|
$ 1.47 | -2.0 % | $ 1.87 M | Nasdaq Capital Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 22.22 | -4.14 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 30.5 | -4.72 % | $ 328 M | Nasdaq Global Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 40.22 | 0.52 % | $ 1.12 B | Nasdaq Global Market,SPB | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 70.62 | 1.55 % | $ 27.3 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 112.72 | 0.52 % | $ 13.8 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.99 | -0.1 % | $ 1.07 B | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 236.0 | - | $ 173 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 107.74 | 0.72 % | $ 4.25 B | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 145.99 | 3.06 % | $ 23.2 B | Nasdaq Global Select Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 12.09 | -2.85 % | $ 343 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fulgent Genetics
FLGT
|
$ 27.79 | -1.03 % | $ 840 M | Nasdaq Global Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 102.27 | -0.16 % | $ 19 B | Nasdaq Capital Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 66.81 | 3.98 % | $ 4.62 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 235.21 | -1.04 % | $ 42.6 B | NYSE,SPB | ||
|
Medpace Holdings
MEDP
|
$ 607.16 | -0.61 % | $ 18.8 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 9.31 | 0.59 % | $ 2.02 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 22.21 | -0.05 % | $ 545 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 220.57 | 0.45 % | $ 11.3 B | NYSE,SPB | ||
|
OPKO Health
OPK
|
$ 1.26 | -1.17 % | $ 874 M | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.38 | 7.69 % | $ 604 M | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 189.77 | 0.14 % | $ 21.1 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 8.95 | 13.58 % | $ 1.16 B | Nasdaq Global Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 404.87 | -3.82 % | $ 29.8 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 274.35 | 1.24 % | $ 23 B | NYSE,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 691.94 | -3.28 % | $ 57.1 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 5.53 | -6.59 % | $ 501 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.7 | -1.67 % | $ 2.52 M | Nasdaq Global Select Market | ||
|
Agilent Technologies
A
|
$ 135.67 | -2.84 % | $ 41.2 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.